TRMT112P2

Across TCGA pan-cancer cohorts, TRMT112P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated TRMT112P2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher TRMT112P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRMT112P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

KICH, UVM, and KIRC are the cancer types where TRMT112P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.589	0.937	<.001	81	view →
UVM	OS	Tertile	II,III,IV	0.218	0.718	.006	72	view →
KIRC	DFS	Tertile	III,IV	0.945	0.672	.004	42	view →
ACC	DFS	Tertile	III,IV	0.047	0.471	<.001	36	view →
SARC	OS	Tertile	All	0.406	0.762	<.001	33	view →
PCPG	OS	Tertile	All	0.010	0.946	<.001	18	view →
STAD	OS	Tertile	All	0.453	0.607	.016	15	view →
THYM	OS	Tertile	All	0.704	0.987	.002	12	view →
LGG	OS	Tertile	All	0.856	0.913	.018	8	view →
ESCA	DFS	Tertile	All	0.201	0.345	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

TRMT112P2–KICH (OS)

Open the KICH breakdown →